Kiniksa Pharmaceuticals KNSA Q1 2026 Earnings EPS Surprises to the Upside as Stock Dips BCAB Q4 2025 Earnings NarrowerthanExpected Loss Drives Positive Stock Reaction ABTC Q1 2026 Earnings Deep EPS Miss Highlights Operational Challenges APWC Q3 1997 Earnings EPS Misses Estimates Amid Cost Pressures ZVRA Q1 2026 Earnings Strong EPS Beat Drives Positive Surprise Yet Stock Slips Slightly ELTK Q1 2026 Earnings Loss Per Share of 042 Shares Rise 608 Despite No Revenue Disclosure